1. Weiss SW, Goldblum JR. Soft Tissue Tumors. 2008. 5th ed. Philadelphia: Mosby.
2. Fletcher CDM, Unni KK, Mertens F. WHO Classification of Tumors, Pathology & Genetics Tumors of Soft Tissue and Bone. 2002. Lyon: IARC Press.
3. Le Doussal V, Coindre JM, Leroux A, Hacene K, Terrier P, Bui NB, et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma. Cancer. 1996. 77:1823–1830.
4. Salo JC, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Malignant fibrous histiocytoma of the extremity. Cancer. 1999. 85:1765–1772.
5. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma. An analysis of 200 cases. Cancer. 1978. 41:2250–2256.
6. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998. 16:197–203.
7. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, et al. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. J Clin Oncol. 1996. 14:869–877.
8. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity. J Clin Oncol. 1992. 10:1317–1329.
9. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996. 14:1679–1689.